Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haskell

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Biology|April 1, 1991
Lovastatin selectively inhibits ras activation of the 12-O-tetradecanoylphorbol-13-acetate response element in mammalian cellsD Defeo-Jones, E M McAvoy, R E Jones, et al.
Oncogene|May 1, 1991
Mammalian cell lines engineered to identify inhibitors of specific signal transduction pathwaysR E Jones, D Defeo-Jones, E M McAvoy, et al.
Clinical Chemistry|October 1, 1981
Increased inactive creatine kinase B protein in the plasma of patients with malignancyM H Burnam, J L Barstis, C S Stern, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 1, 1996
A comparison of body fat estimates using anthropometry and bioelectrical impedance analysis with distinct prediction equations in elderly persons in the Republic of GuatemalaM Mazariegos, C Valdez, S Kraaij, et al.
Cancer|July 1, 1981
Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: six-day subrenal capsule assayA E Bogden, W R Cobb, D J Lepage, et al.
Plos One|August 30, 2008
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signalingQing-Bai She, Sarat Chandarlapaty, Qing Ye, et al.
Nature|July 18, 1991
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene productD Defeo-Jones, P S Huang, R E Jones, et al.
National Cancer Institute Monograph|June 1, 1982
Clinical radiofrequency hyperthermia: a reviewF K Storm, D L Morton, L R Kaiser, et al.
Johns Hopkins Medical Journal. Supplement|January 1, 1974
Experimental and clinical trials with BCG immunotherapyF C Sparks, M J Silverstein, J S Hunt, et al.
The Journal of Trauma|May 29, 1998
The impact of true partnership between a university Level I trauma center and a community Level II trauma center on patient transfer practicesW Schwab, H L Frankel, M F Rotondo, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Biology|April 1, 1991
Lovastatin selectively inhibits ras activation of the 12-O-tetradecanoylphorbol-13-acetate response element in mammalian cellsD Defeo-Jones, E M McAvoy, R E Jones, et al.
Oncogene|May 1, 1991
Mammalian cell lines engineered to identify inhibitors of specific signal transduction pathwaysR E Jones, D Defeo-Jones, E M McAvoy, et al.
Clinical Chemistry|October 1, 1981
Increased inactive creatine kinase B protein in the plasma of patients with malignancyM H Burnam, J L Barstis, C S Stern, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 1, 1996
A comparison of body fat estimates using anthropometry and bioelectrical impedance analysis with distinct prediction equations in elderly persons in the Republic of GuatemalaM Mazariegos, C Valdez, S Kraaij, et al.
Cancer|July 1, 1981
Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: six-day subrenal capsule assayA E Bogden, W R Cobb, D J Lepage, et al.
Plos One|August 30, 2008
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signalingQing-Bai She, Sarat Chandarlapaty, Qing Ye, et al.
Nature|July 18, 1991
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene productD Defeo-Jones, P S Huang, R E Jones, et al.
National Cancer Institute Monograph|June 1, 1982
Clinical radiofrequency hyperthermia: a reviewF K Storm, D L Morton, L R Kaiser, et al.
Johns Hopkins Medical Journal. Supplement|January 1, 1974
Experimental and clinical trials with BCG immunotherapyF C Sparks, M J Silverstein, J S Hunt, et al.
The Journal of Trauma|May 29, 1998
The impact of true partnership between a university Level I trauma center and a community Level II trauma center on patient transfer practicesW Schwab, H L Frankel, M F Rotondo, et al.
Pageof 8